copper peptide ghk-cu clinical study skin Prime Journal March/April 2026 Feature Meet GHK-Cu. The ingredient your

Every flu season is different, and influenza infection can affect people differently

Why do people get BPC-157 and GLP-1 confused

A 12-week facial cream study with 71 women documented increased skin density and thickness, reduced laxity, and improved clarity

FDA cGMP requirements for dietary supplements under 21 CFR Part 111 cover cleanliness, process controls, equipment maintenance, and quality system requirements

Although there are currently no large-scale clinical trials of DPP1 inhibitors specifically for COPD, based on positive results in bronchiectasis studies and mechanism of action analysis, DPP1 inhibitors are expected to provide new treatment options for COPD patients, particularly those with neutrophil inflammation as the main characteristic phenotype may achieve more significant therapeutic benefits